Nimodipine Capsules Generic Name & Formulations
Nimodipine 30mg; soft-gel caps.
Calcium channel blocker (CCB).
Nimodipine Capsules Indications
To improve neurological outcome of subarachnoid hemorrhage from ruptured intracranial berry aneurysms, regardless of post-ictus neurological condition.
Nimodipine Capsules Dosage and Administration
Take on empty stomach. 60mg every 4 hours for 21 consecutive days. Start within 96 hours of subarachnoid hemorrhage. If oral therapy is not feasible, may extract capsule contents into a syringe and give via in situ NG tube, then flush tube with normal saline. Hepatic impairment: 30mg every 4 hours; monitor.
Nimodipine Capsules Contraindications
Nimodipine Capsules Boxed Warnings
Nimodipine Capsules Warnings/Precautions
Not for IV or other parenteral administration (may be fatal). Hepatic impairment. Monitor BP, heart rate. Pregnancy (Cat.C). Nursing mothers: not recommended.
Nimodipine Capsules Pharmacokinetics
Nimodipine Capsules Interactions
May potentiate other calcium channel blockers. Potentiated by cimetidine.
Nimodipine Capsules Adverse Reactions
Decreased blood pressure, GI upset, headache, bradycardia, flushing, edema, rash; rare: intestinal pseudo-obstruction and ileus.
Nimodipine Capsules Clinical Trials
Nimodipine Capsules Note
Formerly known under the brand name Nimotop.
Nimodipine Capsules Patient Counseling